Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity

Annals of Surgical Oncology

Volumn 14, Issue 9, 2007, Pages 2550-2558

  Kusamura, Shigeki ^a   Baratti, Dario ^a   Younan, Rami ^b   Laterza, Barbara ^a   Oliva, Grazia Daniela ^a   Costanzo, Pasqualina ^a   Favaro, Myriam ^a   Gavazzi, Cecilia ^a   Grosso, Federica ^a   Deraco, Marcello ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Hyperthermic Intraperitoneal Chemotherapy; Peritonectomy; Toxicity

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN C;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER MORTALITY; CANCER RISK; CANCER SURGERY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DRUG DOSE REDUCTION; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTHERMIC THERAPY; LEUKOPENIA; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PERITONEUM CANCER; POSTOPERATIVE PERIOD; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; LOGISTIC MODELS; MALE; MIDDLE AGED; MITOMYCIN; MORBIDITY; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 34548557240     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9429-1     Document Type: Article

References (33)

1. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004; 11(4):393-398
2. Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 2003; 83:147-153
3. Ryu KS, Kim JH, Ko HS, Kim JW, Ahn WS, Park YG, Kim SJ, Lee JM. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004; 94:325-332
4. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22:3284-3292
5. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21:3737-3743
6. http://www.peritonealworkshop2006.com. Last access February 2007
7. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29-42
8. Sugarbaker PH. Laser-mode electrosurgery. Cancer Treat Res 1996; 82:375-385
9. Younan R, Kusamura S, Baratti D, Oliva GD, Costanzo P, Favaro M, Gavazzi C, Deraco M. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005; 12(11):910-918
10. Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006; 106(5):1144-1153
11. Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 1996; 15:49-58
12. Fujimoto S, Takahashi M, Kobayashi K, Kure M, Masaoka H, Ohkubo H, Isaka S, Shimazaki J. Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case. Surg Today 1993; 23:1094-1098
13. Rossi CR, Foletto M, Mocellin S, Pilati P, De SM, Deraco M, Cavaliere F, Palatini P, Guasti F, Scalerta R, Lise M. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer 2002; 94:492-499
14. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH. Analysis of morbidity and mortality in 60 patients with peritoneal. carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77:2622-2629
15. Schnake KJ, Sugarbaker PH, Yoo D. Neutropenia following perioperative intraperitoneal chemotherapy. Tumori 1999; 85(1):41-46
16. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-67
17. Richard Sylvester. Planning cancer clinical trials. In: Buyse M E, Staquet Maurice J, Sylvester, Richard J. Cancer Clinical Trials. Methods and practice. First Edition. New York: Oxford University Press,1983:48-63
18. Fujimoto S, Takahashi M, Kobayashi K, Kure M, Masaoka H, Ohkubo H, Isaka S, Shimazaki J. Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case. Surg Today 1993; 23(12):1094-1098
19. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004; 11(4):393-398
20. Gemba M, Nakatani E, Teramoto M, Nakano S. Effect of cisplatin on calcium uptake by rat kidney cortical mitochondria. Toxicol Lett 1987; 38(3):291-297
21. Gordon JA, Gattone VH 2nd. Mitochondrial alterations in cisplatin-induced acute renal failure. Am J Physiol 1986; 250(6 Pt 2):F991-998
22. Nechay BR, Neldon SL. Characteristics of inhibition of human renal adenosine triphosphatases by cisplatin and chloroplatinic acid. Cancer Treat Rep 1984; 68(9):1135-1141
23. Phelps JS, Gandolfi AJ, Brendel K, Dorr RT. Cisplatin nephrotoxicity: in vitro studies with precision-cut rabbit renal cortical slices. Toxicol Appl Pharmacol 1987 30; 90(3):501-512
24. Miura K, Goldstein RS, Pasino DA, Hook JB. Cisplatin nephrotoxicity: role of filtration and tubular transport of Cisplatin in isolated perfused kidneys. Toxicology 1987; 44(2):147-158
25. Fillastre JP, Raguenez-Viotte G. Cisplatin nephrotoxicity. Toxicol Lett 1989; 46(1-3):163-175
26. Seguro AC, Shimizu MH, Kudo LH, dos Santos Rocha A. Renal concentration defect induced by cisplatin. The role of thick ascending limb and papillary collecting duct. Am J Nephrol 1989; 9(1):59-65
27. Jain S, Seymour AE. Mitomycin C associated haemolytic uremic syndrome. Pathology 1987; 19(1):58-61
28. Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, Trillet-Lenoir V, Sayag-Beaujard AC, Francois Y, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003; 10:863-869
29. Smeenk RM, Verwaal VJ, Zoetmulder FA. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures. Eur J Surg Oncol 2006; 32(2):186-190. Epub 2005 Nov 21
30. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6:790-796
31. Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA, Levine EA. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004; 11:178-186
32. Elias D, Raynard B, Boige V, Laplanche A, Estphan G, Malka D, Pocard M. Impact of the extent and duration of cytoreductive surgery on postoperative haematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. J Surg Oncol 2005; 90(4):220-225
33. Gianni L, Sessa C, Capri G, Grasselli G, Bianchi G e Vitali G. Farmaci Chemioterapici. In: Bonadona G, Robustelli Della Cuna G, Valagussa P. eds. Medicina Oncologica, 7th edn. Milano: Masson A MediMedia Company, 2003:583-676